Literature DB >> 10684308

Superantigen expression is driven by both mouse mammary tumor virus long terminal repeat-associated promoters in transgenic mice.

B Salmons1, T Miethke, S Wintersperger, M Müller, G Brem, W H Günzburg.   

Abstract

In addition to the usual retroviral promoter, the mouse mammary tumor virus (MMTV) long terminal repeat carries a second promoter located in the U3 region. Here we show that both of these promoters are independently able to give rise to superantigen activity in transgenic mice. The ability of multiple MMTV promoters to drive superantigen expression underscores its importance in the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684308      PMCID: PMC111782          DOI: 10.1128/jvi.74.6.2900-2902.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

Review 1.  Current perspectives in the biology of mouse mammary tumour virus.

Authors:  B Salmons; W H Günzburg
Journal:  Virus Res       Date:  1987-08       Impact factor: 3.303

2.  On the generation of diversity in endogenous superantigens.

Authors:  B Salmons; S Wintersperger; W H Günzburg
Journal:  Immunol Today       Date:  1994-04

3.  Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat.

Authors:  W H Günzburg; F Heinemann; S Wintersperger; T Miethke; H Wagner; V Erfle; B Salmons
Journal:  Nature       Date:  1993-07-08       Impact factor: 49.962

4.  Negative-acting factor and superantigen are separable activities of the mouse mammary tumor virus long terminal repeat.

Authors:  S Wintersperger; B Salmons; T Miethke; V Erfle; H Wagner; W H Günzburg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.

Authors:  T V Golovkina; A B Jaffe; S R Ross
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus.

Authors:  H Acha-Orbea; A N Shakhov; L Scarpellino; E Kolb; V Müller; A Vessaz-Shaw; R Fuchs; K Blöchlinger; P Rollini; J Billotte
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

7.  Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

8.  An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene.

Authors:  C L Miller; R Garner; V Paetkau
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

9.  Production of mouse mammary tumor virus upon transfection of a recombinant proviral DNA into cultured cells.

Authors:  B Salmons; B Groner; C M Calberg-Bacq; H Ponta
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

10.  Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.

Authors:  T V Golovkina; A Chervonsky; J P Dudley; S R Ross
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

View more
  3 in total

1.  Promoter complex in the central part of the mouse mammary tumor virus long terminal repeat.

Authors:  Francoise Rouault; Shiva Badihi Nejad Asl; Stefanie Rungaldier; Eva Fuchs; Brian Salmons; Walter H Günzburg
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

Review 2.  The Role of APOBECs in Viral Replication.

Authors:  Wendy Kaichun Xu; Hyewon Byun; Jaquelin P Dudley
Journal:  Microorganisms       Date:  2020-11-30

Review 3.  The Viral Origin of Human Breast Cancer: From the Mouse Mammary Tumor Virus (MMTV) to the Human Betaretrovirus (HBRV).

Authors:  Generoso Bevilacqua
Journal:  Viruses       Date:  2022-08-01       Impact factor: 5.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.